GlobalData on MSN15h
Anocca gains European authorisation for Phase I/II trial of pancreatic cancer drugThe trial’s first phase will begin in university hospitals across the Netherlands, Denmark, Germany and Sweden.
Anocca has achieved regulatory approval for its first clinical trial, VIDAR-1, a major milestone in the company’s transition ...
CTA approval marks Anocca’s transition to a clinical-stage companyFirst-in-human VIDAR-1 trial begins with the deployment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback